Literature DB >> 12962154

Detrimental vascular effects of lysophosphatidylcholine is limited by other phospholipid components of low-density lipoprotein.

Susan W S Leung1, Min Huang, Ricky Y K Man.   

Abstract

Current consensus suggests that lysophosphatidylcholine is the major detrimental factor in oxidized low-density lipoprotein that may contribute to the alterations of vasomotor responses associated with atherosclerosis. This study investigated the influences of lysophosphatidylcholine and major lipid components in oxidized low-density lipoprotein on vascular relaxation. We also determine if there was any interaction between these phospholipid components on relaxation. Porcine coronary artery rings were incubated with lysophosphatidylcholine, phosphatidylcholine or sphingomyelin. After contraction by the thromboxane A2 mimetic U46619, rings were relaxed with bradykinin and calcium ionophore A23187. Lysophosphatidylcholine with a higher proportion of stearoyl-lysophosphatidylcholine to palmitoyl-lysophosphatidylcholine ratio caused greater reduction of relaxational responses. While phosphatidylcholine and sphingomyelin had no effect on vascular relaxation, they reduced the ability of lysophosphatidylcholine to impair vascular relaxation. Our results thus suggested that the effectiveness of oxidized low-density lipoprotein at inhibiting vasodilatory responses may be determined by the relative proportion of different types of lysophosphatidylcholine as well as the amount of other phospholipid components: phosphatidylcholine and sphingomyelin.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12962154     DOI: 10.1023/a:1024913721398

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  19 in total

Review 1.  Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity.

Authors:  D Steinberg; S Parthasarathy; T E Carew; J C Khoo; J L Witztum
Journal:  N Engl J Med       Date:  1989-04-06       Impact factor: 91.245

2.  Oxidative modification of low density lipoprotein in normal and hyperlipidemic patients: effect of lysophosphatidylcholine composition on vascular relaxation.

Authors:  L Chen; B Liang; D E Froese; S Liu; J T Wong; K Tran; G M Hatch; D Mymin; E A Kroeger; R Y Man; P C Choy
Journal:  J Lipid Res       Date:  1997-03       Impact factor: 5.922

3.  Lysophosphatidylcholine stimulates phospholipase D in human coronary endothelial cells: role of PKC.

Authors:  D A Cox; M L Cohen
Journal:  Am J Physiol       Date:  1996-10

4.  Protein kinase C inhibitors prevent impairment of endothelium-dependent relaxation by oxidatively modified LDL.

Authors:  M Ohgushi; K Kugiyama; K Fukunaga; T Murohara; S Sugiyama; E Miyamoto; H Yasue
Journal:  Arterioscler Thromb       Date:  1993-10

Review 5.  The oxidation hypothesis of atherosclerosis.

Authors:  J L Witztum
Journal:  Lancet       Date:  1994-09-17       Impact factor: 79.321

6.  Relationship between phospholipase D activation and endothelial vasomotor dysfunction in rabbit aorta.

Authors:  D A Cox; M L Cohen
Journal:  J Pharmacol Exp Ther       Date:  1997-10       Impact factor: 4.030

7.  High-affinity arginine transport of bovine aortic endothelial cells is impaired by lysophosphatidylcholine.

Authors:  K Kikuta; T Sawamura; S Miwa; N Hashimoto; T Masaki
Journal:  Circ Res       Date:  1998-11-30       Impact factor: 17.367

8.  Lysophosphatidylcholine inhibits endothelium-dependent hyperpolarization and N omega-nitro-L-arginine/indomethacin-resistant endothelium-dependent relaxation in the porcine coronary artery.

Authors:  H Eizawa; Y Yui; R Inoue; K Kosuga; R Hattori; T Aoyama; S Sasayama
Journal:  Circulation       Date:  1995-12-15       Impact factor: 29.690

9.  Lysophosphatidylcholine: essential role in the inhibition of endothelium-dependent vasorelaxation by oxidized low density lipoprotein.

Authors:  M Yokoyama; K Hirata; R Miyake; H Akita; Y Ishikawa; H Fukuzaki
Journal:  Biochem Biophys Res Commun       Date:  1990-04-16       Impact factor: 3.575

10.  Lysophosphatidylcholine inhibits relaxation of rabbit abdominal aorta mediated by endothelium-derived nitric oxide and endothelium-derived hyperpolarizing factor independent of protein kinase C activation.

Authors:  C L Cowan; R P Steffen
Journal:  Arterioscler Thromb Vasc Biol       Date:  1995-12       Impact factor: 8.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.